The CXCR4+ PD-L1+ neutrophils population and elevated plasmatic IFN-gamma levels highlighted here present potential targets for therapeutic modulation in the clinical sepsis hyperinflammatory phenotype. The gene discussed is CXCR4; the disease is Sepsis.